September 03, 2025

FDA Approves Denosumab Biosimilars

The FDA approved Bildyos and Bilprevda are providing new options comparable to Prolia and Xgeva for osteoporosis, cancer-related bone disease, and other skeletal conditions.

Conexiant

August 28, 2025

Early Weight Bearing After Surgery Shows Strong Outcomes

Patients allowed to bear weight sooner after calcaneal fracture surgery showed strong functional recovery and low pain, without higher complication rates.

Conexiant

August 27, 2025

Drug for Dizziness May Increase Falls

Researchers find elevated risk across adult age groups, not just in older adults.

Conexiant

August 25, 2025

Three Years Later, Still Pain-Free?

Cognitive functional therapy demonstrates durable effects on disability and pain intensity at 3 years, with outcomes remaining stable beyond the 12-month mark in patients with chronic low back pain

Conexiant

August 19, 2025

‘Enough Is Enough’—But When?

How Bogalusa, Louisiana became a lens on the US gun violence epidemic—where race, poverty, policy, and profit converge and communities bear the cost.

KFF Health News

August 17, 2025

Ultrasound Distinguishes Psoriatic Arthritis Phenotypes

Imaging split psoriatic arthritis into two inflammatory subtypes.

Conexiant

August 18, 2025

Health Groups Respond to 'National Scandal'

With elder homelessness rising, PACE programs funded by Medicaid and Medicare secure housing and health care for low-income seniors, seen in Rhode Island.

KFF Health News

August 14, 2025

Capitellum Osteophytes Linked to Elbow Dysfunction

A novel 3D CT classification system identifies osteophyte distribution in elbow osteoarthritis and demonstrates high diagnostic agreement between observers.

Conexiant

August 11, 2025

FDA Approves Ketamine Product for Surgical Pain Management

PharmaTher has received FDA approval for KETARx, a ketamine therapy for surgical pain management.

Conexiant